
Ask a doctor about a prescription for IMPROZOL 20 mg HARD GASTRO-RESISTANT CAPSULES
Prospect: Information for the User
Improzol 20 mg Hard Gastro-Resistant Capsules EFG
Omeprazole
Read the entire prospectus carefully before starting to take the medication, as it contains important information for you.
Follow the administration instructions for the medication contained in this prospectus or as indicated by your doctor or pharmacist exactly.
Contents of the Prospectus:
This medication contains the active ingredient omeprazole. It belongs to a group of medications called "proton pump inhibitors". These medications work by reducing the amount of acid produced by the stomach.
This medication is indicated in adults for the short-term treatment of reflux symptoms (e.g., heartburn, acid regurgitation).
Reflux is the rise of acid from the stomach to the esophagus, which can become inflamed and painful. This can cause symptoms such as a painful burning sensation in the chest that rises to the throat (heartburn) and a sour taste in the mouth (acid regurgitation).
You may need to take the capsules for 2-3 consecutive days to achieve an improvement in symptoms.
You should consult your doctor if it worsens or does not improve after 14 days.
Do not take Improzol:
Do not takethis medication if you are in any of the above cases. If you are not sure, talk to your doctor or pharmacist before takingomeprazole.
Warnings and precautions
Consult your doctor or pharmacist before taking this medication.
Do not take this medication for more than 14 days without consulting your doctor. If you do not experience relief, or if your symptoms worsen, consult your doctor.
This medication may hide the symptoms of other diseases. Therefore, consult your doctor immediately if you experience any of the following conditions before starting to take this medication or during treatment:
If you experience a skin rash, especially in areas of the skin exposed to the sun, consult your doctor as soon as possible, as it may be necessary to interrupt treatment with this medication. Remember to mention any other symptoms you may notice, such as joint pain.
When taking omeprazole, kidney inflammation may occur. The signs and symptoms may include decreased urine volume or blood in the urine and/or hypersensitivity reactions such as fever, skin rash, and joint stiffness. You should report these signs to your doctor.
Patients should not take omeprazole as a preventive medication.
Children and adolescents
Children and adolescents under 18 years of age should not take this medication.
Taking Improzol with other medications
Tell your doctor or pharmacist if you are taking, have recently taken, or are about to take any other medication. This includes medications purchased without a prescription. This is because omeprazole may affect the mechanism of action of some medications and some medications may affect this medication.
Do not take omeprazole if you are taking a medication that contains nelfinavir(used to treat HIV infection).
Tell your doctor or pharmacist if you are taking any of the following medications:
Taking Improzol with food and drinks
See section 3.
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication. Your doctor will decide if you can take omeprazole during that time.
Omeprazole passes into breast milk but is unlikely to affect the baby when used at therapeutic doses. Your doctor will decide if you can take omeprazole if you are breastfeeding.
Driving and using machines
It is unlikely that this medication will affect your ability to drive or use tools or machines.
Adverse effects such as dizziness and visual disturbances (see section 4) may occur. If they do, you should not drive or use machines.
Improzol contains lactose, sucrose, and sodium
This medication contains lactose and sucrose. If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medication.
This medication contains less than 1 mmol of sodium (23 mg) per capsule; this is, essentially "sodium-free".
Follow the administration instructions for the medication contained in this prospectus or as indicated by your doctor or pharmacist exactly. In case of doubt, ask your doctor or pharmacist.
The recommended dose is one 20 mg capsule once a day for 14 days. Contact your doctor if symptoms do not disappear after this time.
You may need to take the capsules for 2-3 consecutive days to achieve an improvement in symptoms.
How to take this medication
What to do if you have trouble swallowing the capsules
Use in children and adolescents
Children and adolescents under 18 years of age should not take this medication.
If you take more Improzol than you should
If you have taken more omeprazole than recommended, consult your doctor or pharmacist immediately. You can also call the Toxicology Information Service, phone 91 562 04 20, indicating the medication and the amount taken.
If you forget to take Improzol
If you forgot to take a dose, take it as soon as you remember. However, if it is almost time for the next dose, skip the missed dose. Do not take a double dose to make up for the missed doses.
Like all medications, this medication can cause adverse effects, although not everyone will experience them.
If you notice any of the following rare but serious adverse effects, stop taking Improzol and consult your doctor immediately:
This could be "Stevens-Johnson syndrome" or "toxic epidermal necrolysis".
Other adverse effects are:
Common adverse effects(may affect up to 1 in 10 people)
Uncommon adverse effects(may affect up to 1 in 100 people)
Rare adverse effects(may affect up to 1 in 1,000 people)
Very rare adverse effects(may affect up to 1 in 10,000 people)
This may be accompanied by high fever and joint pain (erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis).
Frequency not known (cannot be estimated from available data)
In very rare cases, omeprazole may affect the white blood cells in the blood and cause immunodeficiency. If you have an infection with symptoms such as fever with a severely deteriorated general condition or fever with symptoms of local infection, such as sore throat, mouth, or difficulty urinating, you should consult your doctor as soon as possible to perform a blood test and rule out a lack of white blood cells (agranulocytosis). It is essential that you provide information about the medication you are taking at that time.
Do not worry about this list of possible adverse effects. You may not experience any of them. If you think any of the adverse effects you are experiencing is serious or if you notice any adverse effect not mentioned in this prospectus, inform your doctor or pharmacist.
Reporting adverse effects
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect that does not appear in this prospectus. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medications: www.notificaram.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medication.
Keep this medication out of sight and reach of children.
Do not use this medication after the expiration date that appears on the packaging after CAD. The expiration date is the last day of the month indicated.
Store below 30°C.
Keep this blister pack in the original packaging to protect it from moisture.
Medications should not be thrown away in drains or trash. Deposit the packaging and medications you no longer need in the SIGRE Point of the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medications you no longer need. This way, you will help protect the environment.
Composition of Improzol
The gelatin capsule is composed of: gelatin, indigo carmine (E-132), and quinoline yellow (E-104).
Appearance of the product and package contents
Improzol 20 mg capsules are green with a green cap.
Package sizes:
Packages containing 7 or 14 capsules.
Not all package sizes may be marketed.
Marketing authorization holder and manufacturer
Industria Química y Farmacéutica VIR, S.A.
C/ Laguna 66-68-70, Polígono Industrial Urtinsa II
28923 Alcorcón (Madrid)
Spain
Date of the last revision of this prospectus:March 2023
Detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for IMPROZOL 20 mg HARD GASTRO-RESISTANT CAPSULES – subject to medical assessment and local rules.